Literature DB >> 1871428

Contributing factors of pathogenesis in the Mycobacterium avium complex.

W W Barrow1.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1871428     DOI: 10.1016/0923-2508(91)90115-q

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


× No keyword cloud information.
  9 in total

1.  Cell-free system responsible for internal radiolabeling of glycopeptidolipids of the Mycobacterium avium complex.

Authors:  N Ramasesh; E L Wright; W W Barrow
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Modified lymphocyte response to mitogens induced by the lipopeptide fragment derived from Mycobacterium avium serovar-specific glycopeptidolipids.

Authors:  S K Tassell; M Pourshafie; E L Wright; M G Richmond; W W Barrow
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

3.  Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis.

Authors:  A Lemassu; M Daffé
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

4.  Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8.

Authors:  W W Barrow; T L Davis; E L Wright; V Labrousse; M Bachelet; N Rastogi
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.

Authors:  W W Barrow; E L Wright; K S Goh; N Rastogi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Comparative effects of Mycobacterium avium glycopeptidolipid and lipopeptide fragment on the function and ultrastructure of mononuclear cells.

Authors:  M Pourshafie; Q Ayub; W W Barrow
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

7.  Immunomodulation of human peripheral blood mononuclear cell functions by defined lipid fractions of Mycobacterium avium.

Authors:  W W Barrow; J P de Sousa; T L Davis; E L Wright; M Bachelet; N Rastogi
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Potential drug targets for Mycobacterium avium defined by radiometric drug-inhibitor combination techniques.

Authors:  N Rastogi; K S Goh; E L Wright; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

9.  Utilization of a ts-sacB selection system for the generation of a Mycobacterium avium serovar-8 specific glycopeptidolipid allelic exchange mutant.

Authors:  Vida R Irani; Sun-Hwa Lee; Torsten M Eckstein; Julia M Inamine; John T Belisle; Joel N Maslow
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-09-30       Impact factor: 3.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.